These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7999530)

  • 1. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome.
    Kurita T
    Magnes Res; 1994 Jun; 7(2):155-7. PubMed ID: 7999530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias.
    Perticone F; Ceravolo R; De Novara G; Torchia L; Cloro C
    Magnes Res; 1992 Dec; 5(4):265-72. PubMed ID: 1296762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization.
    Chinushi M; Sugiura H; Komura S; Hirono T; Izumi D; Tagawa M; Furushima H; Aizawa Y
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):844-50. PubMed ID: 16105013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium: case report and review of the literature.
    Simpson JM; Maxwell D; Rosenthal E; Gill H
    Ultrasound Obstet Gynecol; 2009 Oct; 34(4):475-80. PubMed ID: 19731233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn Circ J; 2000 Jun; 64(6):445-51. PubMed ID: 10875735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnesium deficiency and magnesium substitution. Effect on ventricular cardiac arrhythmias of various etiology].
    Zehender M; Meinertz T; Just H
    Herz; 1997 Jun; 22 Suppl 1():56-62. PubMed ID: 9333593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for novel antiarrhythmic strategies. Sicilian Gambit.
    Eur Heart J; 1998 Aug; 19(8):1178-96. PubMed ID: 9740340
    [No Abstract]   [Full Text] [Related]  

  • 8. Macroscopic T wave alternans as a harbinger of sudden death.
    Hohnloser SH
    J Cardiovasc Electrophysiol; 1999 Apr; 10(4):625. PubMed ID: 10355707
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity.
    Wentlandt M; Morris SC; Mitchell SH
    Am J Emerg Med; 2017 May; 35(5):804.e5-804.e6. PubMed ID: 27914889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential utility of pulsed-wave Doppler for prenatal diagnosis of fetal ventricular tachycardia secondary to long QT syndrome.
    Miyoshi T; Sakaguchi H; Shiraishi I; Yoshimatsu J; Ikeda T
    Ultrasound Obstet Gynecol; 2018 May; 51(5):697-699. PubMed ID: 28741754
    [No Abstract]   [Full Text] [Related]  

  • 11. [Marked reduction of life-threatening ventricular tachyarrhythmias in a critically ill patient by intravenous administration of magnesium sulfate].
    Chang KH; Uchikoba K; Obara M; Chinzei M; Sumida T; Arita E; Hanaoka K
    Masui; 2002 Jan; 51(1):56-60. PubMed ID: 11840666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Farouque HM; Sanders P; Young GD
    Am J Cardiol; 2000 Dec; 86(11):1270-2, A9. PubMed ID: 11090808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M
    Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of oral magnesium in a patient with ventricular tachycardia due to hypomagnesemia.
    Tsuji A; Araki K; Maeyama K; Hashimoto K
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):205-8. PubMed ID: 16211210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifekalant hydrochloride terminating sustained ventricular tachycardia accompanied with QT dispersion prolongation.
    Wang J; Hua W; Zhu J; Yang YM; Wang FZ; Pu JL; Chen KP; Zhang S
    Chin Med J (Engl); 2010 Aug; 123(15):2028-33. PubMed ID: 20819537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous magnesium sulfate on cardiac arrhythmias in critically ill patients with low serum ionized magnesium.
    Kasaoka S; Tsuruta R; Nakashima K; Soejima Y; Miura T; Sadamitsu D; Tateishi A; Maekawa T
    Jpn Circ J; 1996 Nov; 60(11):871-5. PubMed ID: 8958195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous magnesium for the treatment of cardiac arrhythmias.
    Arnold DJ
    Aust N Z J Med; 2000 Feb; 30(1):54-60. PubMed ID: 10800879
    [No Abstract]   [Full Text] [Related]  

  • 18. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of anesthesia in children with long QT syndrome.
    Nathan AT; Berkowitz DH; Montenegro LM; Nicolson SC; Vetter VL; Jobes DR
    Anesth Analg; 2011 May; 112(5):1163-8. PubMed ID: 21346158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium-Responsive Polymorphic Ventricular Tachycardia Associated with Alcoholic Binge Drinking.
    Sliman H; Zissman K; Goldstein J; Flugelman MY; Hellman Y
    Isr Med Assoc J; 2016 Jul; 18(7):439-440. PubMed ID: 28471572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.